panitumumab,bevacizumab
amgen,takeda,roche
['panitumumab', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'paradigm']
paradigm results out! folfox plus panitumumab superior to folfox plus bev in the ras wild type metastatic crc pts. pfs similar in the two groups. #asco2022 
Breast cancer specialist. Shoe lover. Cupcake connoisseuse. Opinions are my own, RTs not an endorsement.